Riskpilot← Back to searchSign inGet full accessEncia AB
ABActiveOrg 5568401888UppsalaMedical specialists activities · NACE 8622Est. 20118 employees
Revenue 2024
SEK 37,9M
+6% vs 2023
EBITDA margin
22.8%
-24% vs 2023
Equity ratio
54.4%
Financial strength
Net profit 2024
SEK 29K
-92% vs 2023
| Revenue | SEK 37,9M | +6% |
| EBITDA | SEK 8,6M | -24% |
| Net profit | SEK 29K | -92% |
| Total assets | SEK 12,6M | +1% |
| Equity | SEK 6,9M | +0% |
| Employees | 8 | — |
Legal name
Encia AB
Org number
5568401888
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 februari 2011
Share capital
SEK 50 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva hälso- och sjukvård.
Address
Uppsala
Phone
+46812441460
Email
ekonomi@encia.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 18 897 | 34 193 | 26 805 | 35 630 | 37 942 |
| Staff expenses | — | — | −5 162 | −5 587 | −7 786 |
| EBITDA | 2 219 | 8 213 | 5 896 | 11 430 | 8 647 |
| Depreciation & amort. | −306 | −0 | — | — | — |
| EBIT | 1 913 | 8 213 | 5 896 | 11 430 | 8 647 |
| Net financials | −18 | −11 | −3 | 8 | 20 |
| Profit before tax | 1 716 | 5 928 | 686 | 476 | 55 |
| Tax | −115 | −1 226 | −147 | −112 | −26 |
| Net profit | 1 601 | 4 702 | 539 | 364 | 29 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 628 | 13 701 | 13 003 | 12 459 | 12 607 |
| Equity | 1 225 | 5 927 | 6 232 | 6 830 | 6 859 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 4 224 | 5 612 | 4 375 | 3 285 | 3 583 |
| Total debt | 4 224 | 5 612 | 4 375 | 3 285 | 3 583 |
EBITDA margin
22.8%
This company
15.8%
Market median
+44% vs market
20202024
Equity ratio
54.4%
This company
38.2%
Market median
+42% vs market
20202024
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20202024
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20202024
Asset turnover
3.01×
This company
1.12×
Market median
+169% vs market
20202024
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AG | Audit | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Famwan AB
Encia AB Board members of Encia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Gunnar Rune Sjödelius | Audit | 0 companies |
| Helena Cecilia Wänéus | Chairman | 0 companies |
| Henrik Olof Bertil Wänéus | Deputy Board Member | 0 companies |
| Sven Ivan Karlsson | Chairman | 0 companies |
| Ludwig Olof Henriksson Wänéus | Board of Directors | 0 companies |
| Sara Cecilia Henriksdotter Timm | Board of Directors | 0 companies |